Nirupama Vemuri

Learn More
BACKGROUND Lanthanum carbonate (FOSRENOL®) is an effective, well-tolerated phosphate binder. The ability of lanthanum to reduce serum phosphorus levels to ≤5.5 mg/dL in patients with end-stage renal disease (ESRD) was assessed in a clinical practice setting. METHODS A 16-week, phase IV study enrolled 2763 patients at 223 US sites to evaluate the efficacy(More)
  • 1